Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS). - Wikidata - awgldk - TriplyDB

Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS).

Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS).

http://www.wikidata.org/entity/Q43808890

about

Cardioprotection during cardiac surgery Hyperkalemic cardioplegia for adult and pediatric surgery: end of an era?Intermediate and high peri-operative cardiac enzyme release following isolated coronary artery bypass surgery are independently associated with higher one-year mortality Adjuvant cardioprotection in cardiac surgery: update.Third universal definition of myocardial infarction.Clinical implications of the new definition of myocardial infarction.Increased risk of heart failure as a consequence of perioperative myocardial injury after coronary artery bypass grafting.Cardiac magnetic resonance imaging: long term reproducibility of the late enhancement signal in patients with chronic coronary artery disease.Potential Effect of L-Carnitine on the Prevention of Myocardial Injury after Coronary Artery Bypass Graft Surgery.Ischemia-modified albumin use as a prognostic factor in coronary bypass surgery.Q10 supplementation effects on cardiac enzyme CK-MB and troponin in patients undergoing coronary artery bypass graft: a randomized, double-blinded, placebo-controlled clinical trial Plasma levels of growth differentiation factor-15 are associated with myocardial injury in patients undergoing off-pump coronary artery bypass grafting.Efficacy of coronary revascularization in patients with acute chest pain managed in a chest pain unit Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI).Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy.Myocardial protection in heart surgery.Preservation of myocardium during coronary artery bypass surgery.Volatile anaesthetics and cardioprotection: lessons from animal studies.The clinical significance of cardiac troponins in medical practice.Statin pretreatment and risk of in-hospital atrial fibrillation among patients undergoing cardiac surgery: a collaborative meta-analysis of 11 randomized controlled trials.Changes of cardiac troponin I and operative mortality of coronary artery bypass.Myocardial protection from ischemia-reperfusion injury post coronary revascularization.Clinical Outcomes of Remote Ischemic Preconditioning Prior to Cardiac Surgery: A Meta-Analysis of Randomized Controlled Trials Association between CK-MB Area Under the Curve and Tranexamic Acid Utilization in Patients Undergoing Coronary Artery Bypass Surgery.Single-Dose Lignocaine-Based Blood Cardioplegia in Single Valve Replacement Patients.The significance of troponin T and CK-MB release in coronary artery bypass surgery.End points in clinical trials: are they moving the goalposts?Predictors for physical and mental health 6 months after coronary artery bypass grafting: a cohort study.Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI).Increased ischaemia modified albumin following coronary artery bypass grafting.ESC Joint Working Groups on Cardiovascular Surgery and the Cellular Biology of the Heart Position Paper: Perioperative myocardial injury and infarction in patients undergoing coronary artery bypass graft surgery.Cecilie Greig memorial lecture 2002. Myocardial protection: an expanding or contracting discipline?Third universal definition of myocardial infarction

P2860

Q26866366-A4D073E3-D9ED-4F29-8BA7-1BBB6E2F6905 Q27022674-212F7780-7CF1-4289-8C90-013165C9C238 Q33254062-80045A90-38B8-4654-BC3C-8543B48AFF75 Q34120490-63E6969C-E123-46C9-BAAF-0B7F407035FB Q34295914-454DAEAA-C676-4011-B264-926EEF2F1E60 Q34543932-D18BD23C-7924-4D70-8DF1-451B3963FE3B Q35584264-E8C863BD-00FC-4C32-A450-78286718B221 Q35584601-1602ED22-54CD-4640-B427-A716A7913F2B Q35768718-119CBA9D-30E7-4998-8CA5-6D882D227C8D Q36099107-95558667-587B-48E9-9AEE-5E7FB7E2DB94 Q36785446-D79DD27F-D3BE-449F-98E6-07B278F3F76C Q37014872-F5D10521-B2AD-4B17-AD08-5B8C595E21BA Q37151370-F34D3B90-395E-4E0E-953A-323A418FE3DA Q37472971-E4A11DB5-2C1F-4DBA-84D1-76B363C3C1C8 Q37774078-A5C3C82F-67BF-4098-9E65-9131FE15443B Q37912849-DDC07A0C-3DFA-40E3-8CD1-79157B0034FF Q38005013-476747BD-5927-4B7A-9C20-C99172FB7038 Q38026951-34C662E2-887B-4D79-B475-80C248E5175E Q38130225-3C1924A5-53CA-4574-A80A-F2CC587F1B9F Q38367085-31FC0D9E-38ED-4826-B9DC-B455EA369856 Q38440934-863D7E2A-B080-4ACC-8291-BFF2A22A0E3D Q38552442-C14F3988-0CE7-4103-8908-23DF565F93B8 Q38755171-BC73066D-D7EA-4BCB-A78E-5F32243375EE Q38757917-518C4348-C5B2-4CDE-9211-6842ACFB40A7 Q41845440-C089E263-4856-4F77-B7AE-E3839BD5E200 Q42714876-1141534A-1314-46E8-830A-9F20E2865FC8 Q42833258-FEC208E0-0D72-4956-A961-687FD34FD46A Q43135066-899168D7-DAEC-493C-89C5-960C71EB02D4 Q45839848-0D5868B7-A3CA-456E-ACC6-2D89B30F695C Q46090017-C34FA3A9-3348-4C0F-8397-D817C64A295A Q47261872-CF23F832-22D0-44F1-8616-F00678F90673 Q48568757-565B0986-397B-4BC9-A7A1-1265F0E88FE8 Q57314061-EFEAD6A0-34E6-4CF7-82B6-A41172308A9B

P2860

Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS).

http://www.wikidata.org/entity/Q43808890

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

Incidence, predictors, and sig ...... zation therapies study (ARTS).

@en

Incidence, predictors, and sig ...... zation therapies study (ARTS).

@nl

type

label

Incidence, predictors, and sig ...... zation therapies study (ARTS).

@en

Incidence, predictors, and sig ...... zation therapies study (ARTS).

@nl

prefLabel

Incidence, predictors, and sig ...... zation therapies study (ARTS).

@en

Incidence, predictors, and sig ...... zation therapies study (ARTS).

@nl

P1433

Q43808890-8CA38432-3E01-4EE3-9873-B1BAA7BD6E1D

P1476

Q43808890-F520117B-300D-4BBA-AA0E-1B4650F0A2C0

P2093

Q43808890-2BA9EA53-CD7D-45D8-B9A9-75F93F295483

Q43808890-45117056-CB5D-47C9-811F-3A29928A5954

Q43808890-49F09ADE-4285-4CEE-BE54-5B966030A312

Q43808890-549111BC-6550-4B91-8486-5CAFCF6DE383

Q43808890-5CAA4B38-673F-4ACF-A17D-F70542E37964

Q43808890-712A6CD6-6C83-4879-BFC2-778C572419D2

Q43808890-A638282C-D544-4EEF-8626-54D8AD571D22

Q43808890-B8DB6073-3DAD-4501-AA8C-86505B27EE06

Q43808890-BC0D3863-4039-4803-A736-F7A2AE6D8F95

Q43808890-CA4A9922-393A-4E26-9514-D663F28C5586

P304

Q43808890-836B9BC7-BF67-4F3E-B4EE-7BEFF3604903

P31

Q43808890-402B0A08-33C1-4165-A77C-AB6B096D3D04

P356

Q43808890-AA896320-003A-4B67-8B33-42EEAA2FCA55

P407

Q43808890-9D8177E1-C2CA-4534-878C-3BD3E680A3F6

P433

Q43808890-7F503B1F-B9AD-4C85-A344-202A8528B54C

P478

Q43808890-B2E334BF-3129-4601-A1A5-1A0ADAD7949F

P577

Q43808890-B140275B-FC5A-4551-BAC7-06B7695407C0

P698

Q43808890-C1F1A55C-E4B1-4CB6-939A-B56E20881B84

P921

Q43808890-0001D92A-53D4-4EB0-BECE-C5F1469B0D09

Q43808890-616ECC8B-545A-4A49-BD8E-AAD5BE4D2579

P356

P1433

P1476

Incidence, predictors, and sig ...... zation therapies study (ARTS).

@en

P2093

Carere RG

http://www.w3.org/2001/XMLSchema#string

Castanon JL

http://www.w3.org/2001/XMLSchema#string

Costa MA

http://www.w3.org/2001/XMLSchema#string

Fernandez-Avilèz F

http://www.w3.org/2001/XMLSchema#string

Foley DP

http://www.w3.org/2001/XMLSchema#string

Gonzáles JH

http://www.w3.org/2001/XMLSchema#string

Heyer G

http://www.w3.org/2001/XMLSchema#string

Lichtenstein SV

http://www.w3.org/2001/XMLSchema#string

Lindenboom W

http://www.w3.org/2001/XMLSchema#string

Macaya C

http://www.w3.org/2001/XMLSchema#string

P304

2689-2693

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/HC4701.099789

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P577

2001-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11723020

http://www.w3.org/2001/XMLSchema#string

P921

cardiac surgery

revascularization